Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Royalty Pharma plc Director's Dealing 2022

Apr 16, 2022

30286_dirs_2022-04-15_7b7c4d8e-cb47-4267-98a2-6c5b689c9055.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3/A — Form 3/A

Issuer: Royalty Pharma plc (RPRX)
CIK: 0001802768
Period of Report: 2020-06-15

Reporting Person: Legorreta Pablo G. (Director, CEO, Chairman of the Board)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
LP interests in RPI US Partners 2019, LP $0 Class A Ordinary Shares, par value $0.0001 per share (1584810) Indirect
LP interests in RPI US Partners 2019, LP $0 Class A Ordinary Shares, par value $0.0001 per share (8802380) Indirect
ICAI Interests $0 LP interests in RPI US Partners 2019, LP (1719074) Indirect

Footnotes

F1: Represents limited partnership interests in RPI US Partners 2019, LP ("RPI US LP Interests"). Each RPI US LP Interest can be exchanged for ten Class B Interests in Royalty Pharma Holdings Ltd, ("Holdings") at any time and for no additional value, which exchange right does not expire until so converted. Each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged upon such exchange for one Class A Ordinary Share, par value $0.0001 per share ("Class A Ordinary Share") of the Issuer for no additional value.

F2: These RPI US LP Interests held by the Reporting Person's Spouse were omitted from the Reporting Person's original Form 3 filing due to an inadvertent administrative error.

F3: This amendment to Form 3 is being filed to correct the terms and the number of RPI US LP Interests and ICAI Interests that was incorrectly reported on the Reporting Person's original Form 3 due to an inadvertent administrative error.

F4: These ICAI Interests represent a grant of up to 1,719,074 RPI US LP Interests and expire on December 15, 2023. The full number of RPI US LP Interests is issuable in respect of these ICAI Interests if and when the Class A Ordinary Shares attain a 20-trading day volume weighted average price of $32.30 or more after December 15, 2020 and on or before December 15, 2023. The number of RPI US LP Interests issuable in respect of these ICAI Interests scales linearly from 0% at $20.51 per share to 100% at $32.30 per share.